Global Companion Animal Veterinary Vaccines Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Inactivated, Live Attenuated, Recombinant, and Others.

By Route Of Administration;

Oral, Parenteral, and Others.

By Distribution Channel;

Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn795612901 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Companion Animal Veterinary Vaccines Market (USD Million), 2021 - 2031

In the year 2024, the Global Companion Animal Veterinary Vaccines Market was valued at USD 3,741.78 million. The size of this market is expected to increase to USD 5,917.50 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.8%.

The increasing prevalence of cattle diseases and the expanding livestock population are key drivers fueling the widespread adoption of ruminant vaccines, particularly for cattle, on a global scale. Animals are essential sources of meat, protein, milk, and other commercial products like wool and leather. Among the most commonly used animal vaccines are those targeting rabies, equine influenza virus, and foot and mouth diseases, effectively preventing the transmission of infectious agents by mimicking naturally acquired immunity.

Growing concerns over food security and the rise in animal husbandry practices are driving the demand for vaccines to safeguard the health of livestock populations. The escalating demand for animal products has led to a significant increase in global livestock production. Additionally, factors such as changes in dietary preferences due to evolving lifestyles and population growth further contribute to the rising demand for livestock products, thereby bolstering the market for animal vaccines.

The continuous introduction of technologically advanced vaccines and the occurrence of livestock diseases have reshaped market dynamics. The prevalence of zoonotic diseases, which can transmit from animals to humans, underscores the importance of animal vaccines in protecting public health. Emerging and exotic animal diseases pose significant threats to both human and animal welfare, as well as food security. The increasing populations of humans and animals, coupled with environmental degradation and globalization of trade and travel, create favorable conditions for the transmission of pathogens across species boundaries, leading to the emergence of new diseases.

With the rising demand for animal protein worldwide, commercial food animal production has witnessed considerable growth, resulting in heightened concerns about emerging zoonotic diseases affecting both companion and livestock animals. As such, animal vaccines play a crucial role in controlling the spread of emerging diseases and mitigating their impact on public health. Given the inevitability of continued disease outbreaks in the future, animal vaccines are poised to remain instrumental in addressing the challenges posed by emerging infectious diseases across the globe.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Route Of Administration
    3. Market Snapshot, By Distribution Channel
    4. Market Snapshot, By Region
  4. Global Companion Animal Veterinary Vaccines Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Pet Ownership
        2. Rising Awareness of Pet Health
        3. Advancements in Veterinary Medicine
        4. Government Initiatives and Regulations
        5. Globalization of Pet Trade
      2. Restraints
        1. Limited Awareness and Adoption
        2. Regulatory Hurdles
        3. High Development Costs
        4. Vaccine Safety Concerns
        5. Vaccine Efficacy Challenges
      3. Opportunities
        1. Increasing Pet Ownership
        2. Technological Advancements
        3. Rising Awareness
        4. Government Initiatives
        5. Veterinary Healthcare Infrastructure
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry

  5. Market Segmentation
    1. Global Companion Animal Veterinary Vaccines Market, By Product, 2021 - 2031 (USD Million)
      1. Inactivated
      2. Live Attenuated
      3. Recombinant
      4. Others
    2. Global Companion Animal Veterinary Vaccines Market, By Route Of Administration, 2021 - 2031 (USD Million)
      1. Oral
      2. Parenteral
      3. Others
    3. Global Companion Animal Veterinary Vaccines Market, By Distribution Channel, 2021 - 2031 (USD Million)
      1. Veterinary Hospitals
      2. Veterinary Clinics
      3. Pharmacies & Drug Stores
      4. Others
    4. Global Companion Animal Veterinary Vaccines Market, By Geography, 2021 - 2031 (USD Million)
      1. North America

        1. United States

        2. Canada

      2. Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Nordic

        7. Benelux

        8. Rest of Europe

      3. Asia Pacific

        1. Japan

        2. China

        3. India

        4. Australia & New Zealand

        5. South Korea

        6. ASEAN (Association of South East Asian Countries)

        7. Rest of Asia Pacific

      4. Middle East & Africa

        1. GCC

        2. Israel

        3. South Africa

        4. Rest of Middle East & Africa

      5. Latin America

        1. Brazil

        2. Mexico

        3. Argentina

        4. Rest of Latin America

  6. Competitive Landscape
    1. Company Profiles
      1. Aratana Therapeutics
      2. Bayer
      3. Boehringer Ingelheim
      4. Ceva Santé Animale
      5. Elanco Animal Health
      6. Eli Lilly
      7. Merck
      8. Phibro Animal Health Corporation
      9. Virbac Group
      10. Zoetis
  7. Analyst Views
  8. Future Outlook of the Market